Physician

Daniel Kmetz, M.D.

According to 2025 Medicare claims, Daniel Kmetz, M.D. (NPI: 1659766319) practices urology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is FIRST UROLOGY, PSC (NPI: 1922099811; TIN: 351488175) and primary practice location at 47130-3769.

Kmetz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,498 traditional Medicare patients, billed 8,694 HCPCS/CPT codes, and received $562,743 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,881 prescription claims across 662 beneficiaries totaling $260,540 in drug costs, led by Gemtesa (Vibegron). DME data shows 112 claims. Open Payments data shows 51 records totaling $2,159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $105,697 to $562,743. Similarly, Part D prescription costs have risen steadily, from $802 to $260,540. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	388	5,521	$105,697
2021	1,205	13,969	$518,845
2022	1,234	9,200	$334,566
2023	1,596	12,467	$755,147
2024	1,498	8,694	$562,743

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	36	55	$802
2016	140	194	$2,309
2017	144	213	$1,853
2018	81	130	$2,962
2019	71	109	$1,953
2020	180	354	$20,702
2021	514	1,485	$135,500
2022	625	2,081	$223,237
2023	783	2,386	$293,071
2024	662	1,881	$260,540

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	29	$6,315
2023	N/R	60	$23,847
2024	N/R	112	$41,562

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	495	701	$86
84153	Psa (prostate specific antigen) measurement, total	215	264	$18
74018	X-ray of abdomen, 1 view	205	232	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	440	583	$12
81003	Automated urinalysis test	557	831	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	110	6,272	$99,044
Myrbetriq	Mirabegron	112	5,432	$84,130
Xyosted	Testosterone Enanthate	16	1,232	$27,060
Mirabegron Er	Mirabegron	16	600	$7,212
Tamsulosin Hcl	Tamsulosin Hcl	431	32,174	$4,652

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	35	$32,713
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	41	$8,216
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	24	$510
A4332	Lubricant, individual sterile packet, each	N	N/R	12	$123

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$2,159	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$2,517	Louisville URS Solutions, LLC

Explore More Providers

FAQ

What Medicare data is available for Daniel Kmetz, M.D.?

Tedicare shows public-source Medicare data for Daniel Kmetz, M.D. (NPI 1659766319), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Kmetz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Kmetz, M.D.?

Daniel Kmetz, M.D. is linked to FIRST UROLOGY, PSC (billing NPI 1922099811) in the available physician profile data.

Does Daniel Kmetz, M.D. have Open Payments data?

Daniel Kmetz, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.